Active surveillance in younger patients with prostate cancer: clinical characteristics including longitudinal patient-reported outcomes. (29th December 2022)
- Record Type:
- Journal Article
- Title:
- Active surveillance in younger patients with prostate cancer: clinical characteristics including longitudinal patient-reported outcomes. (29th December 2022)
- Main Title:
- Active surveillance in younger patients with prostate cancer: clinical characteristics including longitudinal patient-reported outcomes
- Authors:
- Tohi, Yoichiro
Kato, Takuma
Matsuda, Iori
Honda, Tomoko
Osaki, Yu
Naito, Hirohito
Matsuoka, Yuki
Okazoe, Homare
Taoka, Rikiya
Ueda, Nobufumi
Sugimoto, Mikio - Abstract:
- Abstract: Objective: this study aimed to evaluate the active surveillance continuation period, treatment intervention rate and health-related quality of life in younger patients. Methods: we prospectively conducted a health-related quality of life survey of patients enrolled in the Prostate Cancer Research International: Active Surveillance-JAPAN study at Kagawa University between January 2010 and December 2020. Health-related quality of life was assessed by mail using a validated Japanese version of the Short-Form 8 Health Survey and Expanded Prostate Cancer Index at active surveillance enrolment and annually thereafter until discontinuation of active surveillance. We divided the patients into two groups, younger (aged <65 years) and older (aged ≥65 years), and compared the two groups. Results: of the 84 patients, 22 were in the younger group. The active surveillance continuation period was shorter in the younger group than in the older group. The 3-year treatment intervention rate was higher in the younger group than in the older group. The majority of the reasons for definitive treatment were related to the protocol, which was similar in both groups (80 versus 76%). The sexual summary scores at active surveillance enrolment were higher in the younger group than in the older group. During active surveillance, the younger group and the older group showed no deterioration in all health-related quality of life scores compared with the scores at the enrolment of activeAbstract: Objective: this study aimed to evaluate the active surveillance continuation period, treatment intervention rate and health-related quality of life in younger patients. Methods: we prospectively conducted a health-related quality of life survey of patients enrolled in the Prostate Cancer Research International: Active Surveillance-JAPAN study at Kagawa University between January 2010 and December 2020. Health-related quality of life was assessed by mail using a validated Japanese version of the Short-Form 8 Health Survey and Expanded Prostate Cancer Index at active surveillance enrolment and annually thereafter until discontinuation of active surveillance. We divided the patients into two groups, younger (aged <65 years) and older (aged ≥65 years), and compared the two groups. Results: of the 84 patients, 22 were in the younger group. The active surveillance continuation period was shorter in the younger group than in the older group. The 3-year treatment intervention rate was higher in the younger group than in the older group. The majority of the reasons for definitive treatment were related to the protocol, which was similar in both groups (80 versus 76%). The sexual summary scores at active surveillance enrolment were higher in the younger group than in the older group. During active surveillance, the younger group and the older group showed no deterioration in all health-related quality of life scores compared with the scores at the enrolment of active surveillance. Conclusions: patient-reported health-related quality of life survey indicated that the health-related quality of life of younger Japanese patients was maintained over time during active surveillance, similar to that of older patients. Abstract : During active surveillance, the health-related quality of life of younger Japanese patients was maintained over time, and the surveillance period was shorter in younger patients compared with older patients. … (more)
- Is Part Of:
- Japanese journal of clinical oncology. Volume 53:Number 4(2023)
- Journal:
- Japanese journal of clinical oncology
- Issue:
- Volume 53:Number 4(2023)
- Issue Display:
- Volume 53, Issue 4 (2023)
- Year:
- 2023
- Volume:
- 53
- Issue:
- 4
- Issue Sort Value:
- 2023-0053-0004-0000
- Page Start:
- 335
- Page End:
- 342
- Publication Date:
- 2022-12-29
- Subjects:
- active surveillance -- quality of life -- patient-reported outcomes -- prostate cancer
Oncology -- Periodicals
Cancer -- Periodicals
616.994005 - Journal URLs:
- http://jjco.oupjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/jjco/hyac201 ↗
- Languages:
- English
- ISSNs:
- 0368-2811
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4651.378000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26796.xml